Alkaline Phosphatase

Alkaline phosphatase (ALP) is an enzyme — essentially a biological “helper protein” — that plays a role in many chemical reactions in the body. Enzymes speed up processes that would otherwise happen too slowly to support life. ALP is found in several tissues, but it is most concentrated in the liver, bile ducts, bones, intestines, and placenta (during pregnancy). When ALP is measured in a blood test, it represents the combined activity coming from these sources.

In the liver, ALP is closely linked to bile production and flow. Bile is a digestive fluid made by the liver that helps break down and absorb fats and fat-soluble vitamins (A, D, E, and K). ALP is present on the surface of bile duct cells, so changes in bile flow or liver stress often show up as changes in ALP levels.

In bone, ALP is produced by osteoblasts — cells responsible for building new bone. These cells use ALP during bone mineralisation, the process of depositing calcium and phosphorus into the bone matrix to keep bones strong and resilient. This is why ALP is naturally higher during periods of growth, such as childhood and adolescence.

Smaller amounts of ALP are produced in the intestines, where it supports gut barrier function and helps detoxify bacterial by-products, and in the kidneys, where it contributes to phosphate handling. Because ALP comes from multiple tissues, interpreting results requires context — looking at other biomarkers, symptoms, and life stage rather than viewing the number in isolation.

ALP sits at the intersection of liver health, bone turnover, digestion, and nutrient status. Abnormal levels — either high or low — can provide early clues about underlying physiological stress before overt disease develops.

When ALP is elevated, it often reflects increased activity in the liver or bones. In the liver, this may indicate impaired bile flow (cholestasis), gallbladder issues, medication effects, alcohol-related stress, or inflammatory conditions affecting the bile ducts. In bones, higher ALP can be seen during rapid bone turnover, healing fractures, or conditions involving increased bone breakdown and rebuilding. Elevated ALP may also appear during pregnancy due to placental production, which is considered normal in that context.

From a digestive and metabolic perspective, bile flow is critical for fat digestion, hormone metabolism, and toxin elimination. Poor bile flow can impair absorption of fat-soluble vitamins, contribute to gut dysbiosis (microbial imbalance), and place additional load on detoxification pathways. Because ALP rises when bile ducts are stressed or obstructed, it can act as an early marker of suboptimal digestive-liver function even when standard liver enzymes are still within range.

When ALP is low, it is often overlooked but can be equally important. Low ALP may suggest micronutrient deficiencies, particularly zinc and magnesium, which are required for ALP production and activity. Chronically low ALP has also been associated with impaired bone mineralisation, low bone turnover, thyroid dysfunction, and reduced protein intake or absorption. In functional medicine, persistently low ALP can signal that the body lacks the raw materials needed for repair, growth, and enzymatic activity.

ALP also interacts with other biomarkers. It is commonly interpreted alongside ALT and AST (liver enzymes), GGT (a marker of bile duct and oxidative stress), bilirubin, calcium, phosphate, and vitamin D. Patterns across these markers provide a clearer picture of whether ALP changes are liver-driven, bone-driven, or nutrition-related.

Dietary factors

ALP is sensitive to overall nutrient intake and absorption. Low protein diets can reduce enzyme production, while inadequate intake of zinc, magnesium, and vitamin B6 may lower ALP activity. Poor fat intake or impaired fat digestion can indirectly affect ALP by reducing absorption of fat-soluble vitamins, particularly vitamin D, which influences bone turnover. Diets very high in alcohol or ultra-processed foods can increase liver stress and raise ALP through bile duct irritation.

Lifestyle factors

Alcohol intake, especially regular or excessive consumption, can increase ALP by stressing bile flow. Sedentary lifestyle and low muscle mass may contribute to lower bone-derived ALP, while intense bone remodeling (for example, after fractures or during growth) can raise it. Chronic stress and sleep disruption indirectly affect ALP through impacts on liver detoxification and nutrient metabolism.

Related biomarkers

ALP is best interpreted alongside GGT (to clarify liver/bile involvement), ALT/AST (hepatocellular stress), bilirubin, and calcium–phosphate balance. Vitamin D status is particularly important, as low vitamin D can drive secondary changes in bone turnover and ALP.

Micronutrient impacts

Zinc deficiency is one of the most common nutritional causes of low ALP. Magnesium and vitamin B6 also play supportive roles in enzyme function. Iron overload or deficiency may indirectly influence ALP through liver stress or impaired energy metabolism.

Environmental influences

Exposure to environmental toxins, certain medications, and endocrine-disrupting chemicals can impair bile flow or liver detoxification, leading to elevated ALP over time.

• Optimal: 30 to 130 U/L 

• Mildly high: 131 to 195 U/L 

• High: >195 U/L

• Low: <30 U/L in adults.

If your results are high

• Focus on supporting liver and bile health while clarifying the source of elevation.

• Dietary strategies include prioritising cruciferous vegetables (such as broccoli, rocket, and cabbage), bitter foods (dandelion greens, radicchio), and adequate protein to support liver enzymes. Limit alcohol and ultra-processed foods.

• Lifestyle support includes moderating alcohol intake, improving sleep consistency, and incorporating regular movement to support bile flow.

• Targeted supplements may include milk thistle, artichoke extract, or taurine, if advised by your healthcare provider.

• Additional tests to consider with clinical guidance include GGT, bilirubin, ALT/AST, and possibly ALP isoenzymes to distinguish liver versus bone sources.

If your results are low

• Support nutrient repletion and digestive efficiency.

• Dietary focus should include zinc-rich foods (oysters, red meat, pumpkin seeds), magnesium-rich foods (leafy greens, nuts, legumes), and sufficient high-quality protein. Ensure adequate dietary fats to support vitamin absorption.

• Lifestyle strategies include addressing digestive symptoms that may impair absorption (such as bloating or chronic diarrhoea) and ensuring adequate caloric intake.

• Supplement support may include zinc, magnesium, or a B-complex, under practitioner supervision.

• Additional tests to consider include zinc status, vitamin D, thyroid markers, and markers of bone turnover if clinically indicated.

1. Lala, V., Goyal, A., & Bansal, P. (2023). Alkaline Phosphatase. StatPearls Publishing.

2. Whitfield, J. B. (2001). Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences, 38(4), 263–355.

3. Cashman, K. D. (2007). Diet, nutrition, and bone health. Journal of Nutrition, 137(11), 2507S–2512S.

4. Prasad, A. S. (2013). Discovery of human zinc deficiency. Nutrition, 29(6), 987–993.

5. Kaplan, M. M. (1993). Alkaline phosphatase. Gastroenterology, 105(6), 1970–1978.